Maryland Oncology Hematology PA-Aquilino Cancer Center — Rockville, Maryland

Maryland Oncology Hematology PA-Aquilino Cancer Center is a clinical research site located in Rockville, Maryland, United States 20850.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Maryland Oncology Hematology PA-Aquilino Cancer Center has participated in 9 clinical trials with 4 currently active.

Therapeutic areas: Breast Adenocarcinoma, Advanced Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma.

Sponsors: National Cancer Institute (NCI), NRG Oncology.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Maryland Oncology Hematology PA-Aquilino Cancer Center?

Maryland Oncology Hematology PA-Aquilino Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Maryland Oncology Hematology PA-Aquilino Cancer Center conducted?

Maryland Oncology Hematology PA-Aquilino Cancer Center has 9 clinical trials on record, with 4 currently active. Their work covers Breast Adenocarcinoma, Advanced Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma.

Is Maryland Oncology Hematology PA-Aquilino Cancer Center accredited by Crixeo Health?

Yes — Maryland Oncology Hematology PA-Aquilino Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Maryland Oncology Hematology PA-Aquilino Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.